Biblioteca Humberto Rosselli Quijano
Información del autor
Autor John M. Davis |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Differences in antipsychotic treatment discontinuation among veterans with schizophrenia in the U.S. Department of veterans affairs / Mark Weiser en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.10 (Octubre)
[artículo]
Título : Differences in antipsychotic treatment discontinuation among veterans with schizophrenia in the U.S. Department of veterans affairs Tipo de documento: texto impreso Autores: Mark Weiser, Autor ; John M. Davis, Autor ; Clayton H. Brown, Autor Fecha de publicación: 2021 Artículo en la página: pp. 932-940 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Inyectable de acción prolongada, Suspensión del tratamiento, Esquizofrenia Resumen: Effectiveness of antipsychotic drugs is inferred from relatively small randomized clinical trials conducted with carefully selected and monitored participants. This evidence is not necessarily generalizable to individuals treated in daily clinical practice. The authors compared the clinical effectiveness between all oral and long-acting injectable (LAI) antipsychotic medications used in the treatment of schizophrenia in the U.S. Department of Veterans Affairs (VA) health care system. Link: ./index.php?lvl=notice_display&id=27616
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.10 (Octubre) . - pp. 932-940[artículo] Differences in antipsychotic treatment discontinuation among veterans with schizophrenia in the U.S. Department of veterans affairs [texto impreso] / Mark Weiser, Autor ; John M. Davis, Autor ; Clayton H. Brown, Autor . - 2021 . - pp. 932-940.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.10 (Octubre) . - pp. 932-940
Palabras clave: Antipsicóticos, Inyectable de acción prolongada, Suspensión del tratamiento, Esquizofrenia Resumen: Effectiveness of antipsychotic drugs is inferred from relatively small randomized clinical trials conducted with carefully selected and monitored participants. This evidence is not necessarily generalizable to individuals treated in daily clinical practice. The authors compared the clinical effectiveness between all oral and long-acting injectable (LAI) antipsychotic medications used in the treatment of schizophrenia in the U.S. Department of Veterans Affairs (VA) health care system. Link: ./index.php?lvl=notice_display&id=27616